Evidence map›Paper›PMID 31780740›Full record

ArticleScientific reports2019

µ-opioid receptor-mediated downregulation of midline thalamic pathways to basal and central amygdala.

L Goedecke, X Bengoetxea, P Blaesse, H-C Pape, K Jüngling

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Brain circuits for pain and its treatment.Science translational medicine · 2021
    Review
  10. Article
  11. Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

L GoedeckeInstitute of Physiology I, Westfaelische Wilhelms-Universitaet Muenster, Muenster, Germany. lena.goedecke@ukmuenster.de.
X BengoetxeaInstitute of Physiology I, Westfaelische Wilhelms-Universitaet Muenster, Muenster, Germany.
P BlaesseInstitute of Physiology I, Westfaelische Wilhelms-Universitaet Muenster, Muenster, Germany.
H-C PapeInstitute of Physiology I, Westfaelische Wilhelms-Universitaet Muenster, Muenster, Germany.
K JünglingInstitute of Physiology I, Westfaelische Wilhelms-Universitaet Muenster, Muenster, Germany.
University of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain µ-opioid receptors (MOR) mediate reward and help coping with pain, social rejection, anxiety and depression. The dorsal midline thalamus (dMT) integrates visceral/emotional signals and biases behavior towards aversive or defensive states through projections to the amygdala. While a dense MOR expression in the dMT has been described, the exact cellular and synaptic mechanisms of µ-opioidergic modulation in the dMT-amygdala circuitry remain unresolved. Here, we hypothesized that MORs are important negative modulators of dMT-amygdala excitatory networks. Using retrograde tracers and targeted channelrhodopsin expression in combination with patch-clamp electrophysiology, we found that projections of dMT neurons onto both basal amygdala principal neurons (BA PN) and central amygdala (CeL) neurons are attenuated by stimulation of somatic or synaptic MORs. Importantly, dMT efferents to the amygdala drive feedforward excitation of centromedial amygdala neurons (CeM), which is dampened by MOR activation. This downregulation of excitatory activity in dMT-amygdala networks puts the µ-opioid system in a position to ameliorate aversive or defensive behavioral states associated with stress, withdrawal, physical pain or social rejection.

Indexed as

Action PotentialsAmygdalaAnimalsChannelrhodopsinsDown-RegulationMiceMice, Inbred C57BLNeural PathwaysNeuronsReceptors, Opioid, muThalamusChannelrhodopsinsReceptors, Opioid, mu

Identifiers

PMID31780740
PMCPMC6882837
OpenAlexW2989891679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.